🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and tolerability of RAD...
Status
Completed
Location
Columbus Children's Hospital
Start Date
2000-06
Trial ID
NCT00098241
Treatments Being Tested
The objective of the study is to compare the cardiovascular profile of an e...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-08
Trial ID
NCT01169701
Treatments Being Tested
The purpose of this study is to understand the effects of everolimus on tac...
Status
Completed
Location
National Taiwan University Hospital
Start Date
2014-04
Trial ID
NCT02077556
Treatments Being Tested
This study will assess whether a calcineurin inhibitor (CNI)-free regimen w...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-02-24
Trial ID
NCT00862979
Adult patients with gastric carcinoma which has progressed after initial tr...
Status
Completed
Location
Krankenhaus Nordwest
Start Date
2011-10
Trial ID
NCT01248403
Treatments Being Tested
In the present study, the investigators propose a conversion scheme with 50...
Status
Terminated
Location
Hospital São João de Deus/Fundação Geraldo Corrêa
Start Date
2013-03
Trial ID
NCT01609673
Treatments Being Tested
The purpose of this study was to determine whether an early Calcineurin Inh...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-08-09
Trial ID
NCT01114529
Treatments Being Tested
This study will assess safety and efficacy of AEB071 combined with everolim...
Status
Completed
Location
Argentina
Start Date
2007-07
Trial ID
NCT00504543
This phase I trial studies the side effects and best dose of cixutumumab wh...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2010-10
Trial ID
NCT01204476
Treatments Being Tested
This phase II trial studies molecular profiling-based assignment of cancer ...
Status
Completed
Location
University of Colorado Hospital
Start Date
2014-01-07
Trial ID
NCT01827384
Treatments Being Tested